CDT Equity Inc.
No enriched coverage for $CDT in the last 7 days.
No SEC Form 4 filings for $CDT in the last 30 days.
See all $CDT insider activity →CDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 SECOND AMENDMENT TO LOAN AGREEMENT AND SECOND AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTE This Second Amendment to Loan Agreement and Second Amendment to Senior Secured Convertible Note (this “Amendment” ) is entered into as of July 31,
CDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 ex10-1.htm EX-10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT , dated as of July 30, 2026 (this “ Agreement ”), is entered into by and among CDT Equity Inc., a Delaware corporation (the “ Company ”), and the investor identified on the
CDT Equity Inc. (CDT) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. false 0001896212 0001896212 2026-07-24 2026-07-24 0001896212 CDT:CommonStock0.0001ParValuePerShareMember 2026-07-24 2026-07-24 0001896212 CDT:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockMember 2026-07-24 2026-07-24 iso4217:USD xbrli:shares iso4217:USD xbr
Recent CDT coverage spans corporate actions, financial news and insider activity.
The filing signals a negotiated restructuring of CDT’s convertible debt terms after missed minimum installment payments, with higher cash-flow priority to the lender.
The filing signals a capital raise via a structured equity issuance (pre-funded warrants) funded by an investor in exchange for Sarborg Limited shares.
The filing signals a small, dilutive equity issuance under a Section 4(a)(2) exemption, which can modestly affect near-term float and sentiment.
Reverse split should mechanically lift the quoted share price but does not change proportional ownership; near-term trading may hinge on Nasdaq compliance expectations and dilution risk perception.
The 8-K discloses a new tranche and amended terms for CDT’s secured convertible debt, increasing near-term financing and dilution/convertibility risk.
alphai scores every news story that mentions CDT with an AI model for sentiment and relevance, and aggregates insider trades from CDT Equity Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 SECOND AMENDMENT TO LOAN AGREEMENT AND SECOND AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTE This Second Amendment to Loan Agreement and Second Amendment to Senior Secured Convertible Note (this “Amendment” ) is entered into as of July 31,
6 min readCDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 ex10-1.htm EX-10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT , dated as of July 30, 2026 (this “ Agreement ”), is entered into by and among CDT Equity Inc., a Delaware corporation (the “ Company ”), and the investor identified on the
4 min readCDT Equity Inc. (CDT) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. false 0001896212 0001896212 2026-07-24 2026-07-24 0001896212 CDT:CommonStock0.0001ParValuePerShareMember 2026-07-24 2026-07-24 0001896212 CDT:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockMember 2026-07-24 2026-07-24 iso4217:USD xbrli:shares iso4217:USD xbr
2 min readCDT Equity Inc. (CDT) announced a 1-for-10 reverse stock split effective July 17, 2026, to raise its share price and maintain Nasdaq minimum bid compliance. The consolidation would reduce shares outstanding to 631,077. CDT said ownership and voting rights are unchanged, with cash paid for fractional shares. CDT last traded at $0.31, down 9.69%.
2 min readCDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.2 3 ex10-2.htm EX-10.2 Exhibit 10.2 AMENDED AND RESTATED LOAN AGREEMENT This Amended and Restated Loan Agreement (this “ Agreement ”) is dated as of June 30, 2026 (the “ Agreement Date ”) and is made and entered into between CDT Equity Inc. , (formerly Conduit Pharmaceutica
4 min readTaylor Mark Andrew sold 2,068,000 indirectly-held shares of CDT Equity Inc. (CDT) at an average of $1.42 ($0.71–$1.44, $2.95M total) across 4 trades on 2026-06-18.
2 min readCDT Equity (NASDAQ:CDT) rose in premarket trading after the company said it received new funding tied to Sarborg Ltd. The report states the transaction was completed at $125,000 per share, implying a fully diluted Sarborg valuation of about $638.3 million. Proceeds are earmarked for SarborgQ launch and development, including its quantum computing and AI platform.
4 min readCDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 ex10-1.htm EX-10.1 Exhibit 10.1 LOAN AGREEMENT This Loan Agreement (this “ Agreement ”) is dated as of June 11, 2026 (the “ Agreement Date ”) and is made and entered into between CDT Equity Inc. , (formerly Conduit Pharmaceuticals Inc.) a Delaware corporation (the “ Com
4 min readCDT Equity Inc. (Nasdaq: CDT) said it restructured debt by repaying all amounts due under its Loan Notes with Alliance Global Partners and Ascent Partners, eliminating more than $6.3 million of legacy financing obligations. It also entered a new loan agreement with JJ Astor for up to $1.46 million; the first tranche was about $268k, with the remainder subject to conditions in June 2026.
3 min readCDT (NASDAQ: CDT) has increased its at-the-market (ATM) offering capacity to $76.1 million under its Sales Agreement with A.G.P./Alliance Global Partners. This expansion from a prior capacity of $3.5 million was possible because the company's public float exceeded $75.0 million as of March 24, 2026, allowing it to utilize General Instruction I.B.1 of Form S-3. The company, which is an emerging growth and smaller reporting company, noted a last reported sale price of $5.10 per share on April 1, 2026.
2 min read
